Chagas' disease and the use of implantable cardioverter-defibrillators in Brazil.
The authors discuss the epidemiology and pathogenesis of Chagas' disease in Brazil, including the use of treatment with a cardioverter-defibrillator in patients with low ejection fraction. Select patients may benefit from resynchronization therapy associated with cardioverter-defibrillator treatment. Electrophysiologic study is indicated in the assessment of the potential utility of an implantable cardioverter-defibrillator.
Rosa
Ronaldo F
RF
Geriatric Cardiology Department, Brazilian Cardiology Society and Santa Casa Hospital, Rua Dias Leme 11, CEP 03118-040 São Paulo, SP, Brazil. dr.ronaldo@terra.com.br
Neto
Argemiro S
AS
Franken
Roberto A
RA
D001938:Brazil / Q000453:epidemiology; D002598:Chagas Cardiomyopathy / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D014355:Chagas Disease / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy*; D017147:Defibrillators, Implantable; D006801:Humans; D013318:Stroke Volume